Insights PreviousNextSubscribe to HTA QuarterlyGet at-a-glance updates on important HTA decisions. Each edition of the HTA Quarterly provides insight into the evolving perspectives and priorities for HTAs.Read MoreSubscribe to Health Policy WeeklyRecaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry.Read More1 of 0 Items ISPOR Vienna Presentation: New Value Frameworks in the United States: Insights from Payers, Considerations for Manufacturers,and Implications for Other Regions of the WorldNovember 2016 | In our ISPOR Vienna Symposium presentation, we examine US value constructs that were released in 2015, including the Memorial Sloan Kettering Cancer Center (MSKCC) DrugAbacus, American Society of Clinical Oncology (ASCO) Value Framework, and the Institute for Clinical and Economic Review (ICER) Evidence Reports. We discuss the strengths and weaknesses of each, share perspectives regarding how pharma and US payers view value constructs, and examine implications for other regions of the world. MoreUpping the Game: How drug manufacturers, health systems and payers can collaborate more closely in the new world of patient-minded care.How can manufacturers collaborate with health systems to positively affect patient-minded care? How can health systems and manufacturers share information and expertise to improve the patient experience and outcomes? In this issue brief, we take a closer look at three anchors of collaboration: medication access for patients, medication adherence and transitional care. MoreUsing Data to Unlock the Patient ExperienceIn the healthcare arena, big data is an umbrella term that encompasses volumes of data related to patient health and well-being, disease diagnoses and progress, tests performed, lab results, medications prescribed or administered, side effects and more. The data sets that comprise big data are large, complex and unruly. Mike Eaddy, PharmD, PhD, Vice President of Real-world Evidence, breaks down what's needed to uncover meaningful data for meaningful conclusions. MoreAssessing Value in Oncology: Models & Perspectives from Payers and OncologistsIn this issue brief, we recap 3 value assessment models currently at the forefront of discussions in the US and provide some perspectives from payers and oncologists. MoreTry Out the HTA Decision MapXcenda's Decision Map makes it easy to stay informed on key HTA decisions from Australia, Canada, France, Germany, and the United Kingdom. MoreHTA Quarterly Archive: Insights to Bridge Science and PolicyFind articles from current and past issues of the HTA Quarterly, Xcenda's e-newsletter written specifically by and for health economics and market access professionals. MoreHealth Policy Weekly ArchiveMiss a recent issue? Get up to date with the latest regulatory and legislative happenings and news that impact stakeholders in the healthcare industry. More Explore More InsightsWe invite you to explore our library of articles, webcasts, white papers, and more.